Recordati SpA (MIL:REC)
€ 51.1 0.05 (0.1%) Market Cap: 10.55 Bil Enterprise Value: 11.87 Bil PE Ratio: 25.26 PB Ratio: 5.61 GF Score: 95/100

Q4 2023 Recordati Industria Chimica e Farmaceutica SpA Earnings Call Transcript

Feb 22, 2024 / 03:00PM GMT
Release Date Price: €51.68 (-0.77%)
Operator

Good afternoon. Welcome and thank you for joining the Recordati Full Year 2023 Preliminary Results (Operator Instruction]. At this time, I would like to turn the conference over to Ms. Eugenia Litz, Head of Investor Relations of Recordati. Please go ahead, madam.

Eugenia Litz

Thank you, Sabrina, and good afternoon, everyone. I'm pleased to be here today with Rob Koremans, our CEO; and Luigi La Corte, our CFO, who together will present the full year 2023 results. Also joining for the Q&A session will be Alberto Martinez, Executive Vice President of Specialty & Primary Care; and Scott Pescatore, Executive Vice President of Rare Diseases. As always, the presentation is available in the Investors section of our website.

It is now my pleasure to pass the call over to Rob. Please go ahead.

Robert Koremans
Recordati Industria Chimica e Farmaceutica S.p.A. - CEO & Director

Good afternoon, and thank you for joining us today. Before moving on, please let me give a warm welcome to Eugenia Litz, our new Head of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot